Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to produce and release growth hormone in a natural pulsatile pattern — unlike synthetic HGH injections which deliver exogenous hormone directly and suppress endogenous production.
Sermorelin has no FDA-approved commercial equivalent currently on the market. Compounding pharmacies are the only legal source for sermorelin peptide preparations in the US, making compounding essential rather than optional for patients seeking this therapy.
Compare up to 7,500 pharmacies across the USA.
Sermorelin acetate is a synthetic 29-amino acid analog of endogenous growth hormone-releasing hormone (GHRH). It acts on the pituitary gland's GHRH receptors to stimulate the natural, pulsatile release of growth hormone — the same physiological pattern the body uses in youth.
As adults age, GHRH secretion declines and growth hormone output falls. This contributes to reduced muscle mass, increased visceral fat, impaired sleep quality, reduced bone density, decreased energy, and slower recovery from injury. Sermorelin therapy aims to restore youthful GH pulsatility and its downstream effects.
Unlike synthetic HGH (somatropin), sermorelin works through the body's own regulatory feedback loops — making it physiologically safer, less likely to cause supraphysiologic GH levels, and significantly more affordable. It is available exclusively through licensed compounding pharmacies.
GHRH Receptor Agonism
Sermorelin binds to GHRH receptors on pituitary somatotroph cells, stimulating GH synthesis and pulsatile release. Unlike exogenous HGH, this preserves the body's own feedback mechanisms.
IGF-1 Stimulation
Released GH travels to the liver and peripheral tissues, stimulating IGF-1 (insulin-like growth factor 1) production — the primary mediator of GH's anabolic effects on muscle, bone, and fat metabolism.
Physiological Safety Advantage
Because sermorelin works through natural feedback loops, it cannot produce the supraphysiologic GH levels seen with exogenous HGH that raise risks of acromegaly, insulin resistance, and joint/tissue overgrowth.
Anti-aging / Longevity: Declining GH levels, age-related body composition changes, skin quality
Body Composition: Lean muscle preservation and growth, visceral fat reduction
Recovery: Injury recovery, post-surgical healing, athletic performance
Sleep: Deep sleep enhancement (GH is released primarily during slow-wave sleep)
Pediatric: Growth hormone deficiency in children (original primary indication)
Standard adult protocol: 200–300mcg SubQ injection nightly at bedtime
Athletic/body composition: 200–500mcg nightly or split morning/evening dosing
Duration: Minimum 3–6 month commitment for noticeable results; many continue long-term
Nightly dosing leverages the body's natural overnight GH pulse. IGF-1 levels are monitored at 3–6 months to assess response.
Start at 100–200mcg nightly for the first 2–4 weeks to assess tolerance. Some patients experience initial water retention or joint aching as GH levels rise — this typically resolves. IGF-1 should be measured at baseline and 3 months to optimize dosing. Cycling (5 days on, 2 days off) is common to prevent receptor downregulation.
Common:
Less Common:
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
